Canada markets closed

MYND Life Sciences Inc. (MYND.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.06000.0000 (0.00%)
At close: 03:06PM EDT
Full screen
Previous Close0.0600
Open0.0000
Bid0.0600 x N/A
Ask0.0700 x N/A
Day's Range0.0600 - 0.0600
52 Week Range0.0250 - 0.2900
Volume0
Avg. Volume15,135
Market Cap2.809M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    MYND Life Sciences Inc. Achieves a Major Milestone and Provides Default Status Report

    Identification of a potent, monomolecular non-hallucinogenic analog of psilocybin 100 times stronger than psilocybin. Vancouver, British Columbia--(Newsfile Corp. - March 14, 2023) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating innovative precision medicines and diagnostic solutions for patients with relentless neurological diseases, announced that it has successfully accomplished a significant milesto

  • Newsfile

    MYND Life Sciences Inc. Granted Management Cease Trade Order

    Vancouver, British Columbia--(Newsfile Corp. - March 1, 2023) - MYND Life Sciences Inc. (CSE: MYND) ("MYND" or the "Company") announces that it has been advised by its external auditors (the "Auditors") that they will not be in a position to complete their work on the Company's annual consolidated financial statements for the year ended October 31, 2022 (the "2022 Financial Statements") prior to the filing deadline of February 28, 2023 (the "Annual Filing Deadline"). ...

  • Newsfile

    MYND Life Sciences Announces the Sale of Leasehold Tenant Improvements and Health Canada Cannabis License

    Vancouver, British Columbia--(Newsfile Corp. - February 9, 2023) - MYND Life Sciences Inc. (CSE: MYND) (OTCQB: MYNDF) ("MYND" or the "Company"), a biopharmaceutical research and development company creating innovated and precision medicines for patients with relentless neurological diseases, is pleased to announce the disposition of the Company's leasehold agreement at 733 Finns Road, Kelowna with tenant improvements and a Health Canada cannabis license for an aggregate $1,000,000. The 733 Finns